Genetic polymorphisms in UDP-Glucuronosyltransferase 1A6 are not associated with NSAIDs-related peptic ulcer haemorrhage

Drug Metabolism Letters

Volumn 3, Issue 3, 2009, Pages 199-204

  Van Oijen, Martijn G H ^a   Koetsier, Marjolein I A ^a   Laheij, Robert J F ^a   Roelofs, Hennie M J ^a   Te Morsche, René H M ^a   Peters, Wilbert H M ^a   Verheugt, Freek W A ^a   Jansen, Jan B M J ^a   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspirin; Genetic polymorphism; Non steroidal anti inflammatory drugs; UDP glucuronosyltransferase 1A6; Upper gastrointestinal bleeding; Upper gastrointestinal symptoms

Indexed keywords

ACETYLSALICYLIC ACID; GLUCURONOSYLTRANSFERASE 1A6; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIC ULCER HEMORRHAGE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 70350724559     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231209789352111     Document Type: Article

References (29)

1. Kaufman, D.W.; Kelly, J.P.; Sheehan, J.E.; Laszlo, A.; Wiholm, B.E.; Alfredsson, L.; Koff, R.S.; Shapiro, S. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin. Pharmacol. Ther., 1993, 53, 485-494. (Pubitemid 23119438)
2. Kelly, J.P.; Kaufman, D.W.; Jurgelon, J.M.; Sheehan, J.; Koff, R.S.; Shapiro, S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet, 1996, 348, 1413-1416. (Pubitemid 26395236)
3. Wilcox, C.M.; Alexander, L.N.; Cotsonis, G.A.; Clark, W.S. Non-steroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig. Dis. Sci., 1997, 42, 990-997.
4. Wolfe, M.M.; Lichtenstein, D.R.; Singh, G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med., 1999, 340, 1888-1899. (Pubitemid 29272670)
5. Garcia Rodriguez, L.A.; Jick, H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet, 1994, 343, 769-772.
6. Sorensen, H.T.; Mellemkjaer, L.; Blot, W.J.; Nielsen, G.L.; Steffensen, F.H.; McLaughlin, J.K.; Olsen, J.H. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am. J. Gastroenterol., 2000, 95, 2218-2224. (Pubitemid 30707381)
7. Kurzawski, M.; Gawronska-Szklarz, B.; Wrzesniewska, J.; Siuda, A.; Starzynska, T.; Drozdzik, M. Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients. Eur. J. Clin. Pharmacol., 2006, 62, 877-880.
8. Tukey, R.H.; Strassburg, C.P. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol. Pharmacol., 2001, 59, 405-414.
9. Ciotti, M.; Marrone, A.; Potter, C.; Owens, I.S. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics, 1997, 7, 485-495.
10. Bigler, J.; Whitton, J.; Lampe, J.W.; Fosdick, L.; Bostick, R.M.; Potter, J.D. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res., 2001, 61, 3566-3569.
11. Kuehl, G.E.; Lampe, J.W.; Potter, J.D.; Bigler, J. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab. Dispos., 2005, 33, 1027-1035.
12. Kuehl, G.E.; Bigler, J.; Potter, J.D.; Lampe, J.W. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes. Drug Metab. Dispos., 2006, 34, 199-202.
13. McGreavey, L.E.; Turner, F.; Smith, G.; Boylan, K.; Timothy, B.D.; Forman, D.; Wolf, C.R.; Barrett, J.H.; Colorectal Cancer Study Group. No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma. Pharmacogenet. Genomics, 2005, 15, 713-721.
14. Chen, Y.; Kuehl, G.E.; Bigler, J.; Rimorin, C.F.; Schwarz, Y.; Shen, D.D.; Lampe, J.W. UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin. Pharmacogenet. Genomics, 2007, 17, 571-579.
15. Nagar, S.; Zalatoris, J.J.; Blanchard, R.L. Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics, 2004, 14, 487-499.
16. Marshall, B.J.; Warren, J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1984, 1, 1311-1315.
17. De Leest, H.T.; Steen, K.S.; van Wijngaarden, S.; Lems, W.F.; van der Laar, M.A.; Dijkmans, B.A. The prevalence of H. pylori is still substantial in rheumatic patients. Scand. J. Rheumatol., 2002, 31, 94-96. (Pubitemid 34518088)
18. Van Oijen, M.G.H.; Huybers, S.; Peters, W.H.M.; Drenth, J.P.H.; Laheij, R.J.F.; Verheugt, F.W.A.; Jansen, J.B.M.J. Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid. Br. J. Clin. Pharmacol., 2005, 60, 623-628.
19. Leong, R.W.; Chan, F.K.; Sung, J.J. Helicobacter pylori and non-steroidal anti-inflammatory drugs. Approaching the end of the controversy in the new millennium, or room for more debate? J. Gastroenterol., 2001, 36, 731-739.
20. Sung, J.J. Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users? Aliment. Pharmacol. Ther., 2004, 20(Suppl 2), 65-70.
21. Sturkenboom, M.C.; Burke, T.A.; Dieleman, J.P.; Tangelder, M.J.; Lee, F.; Goldstein, J.L. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford), 2003, 42 (Suppl 3), iii23-iii31.
22. Sturkenboom, M.C.; Burke, T.A.; Tangelder, M.J.; Dieleman, J.P.; Walton, S.; Goldstein, J.L. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs. Aliment. Pharmacol. Ther., 2003, 18, 1137-1147.
23. Samowitz, W.S.; Wolff, R.K.; Curtin, K.; Sweeney, C.; Ma, K.N.; Andersen, K.; Levin, T.R.; Slattery, M.L. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal antiinflammatory drugs in colorectal cancer prevention. Clin. Gastroenterol. Hepatol.,. 2006, 4, 894-901.
24. Lampe, J.W.; Bigler, J.; Horner, N.K.; Potter, J.D. UDP- glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics, 1999, 9, 341-349.
25. Hutt, A.J.; Caldwell, J.; Smith, R.L. The metabolism of aspirin in man: a population study. Xenobiotica, 1986, 16, 239-249.
26. Whittle, B.J.; Higgs, G.A.; Eakins, K.E.; Moncada, S.; Vane, J.R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature, 1980, 284, 271-273.
27. Van Oijen, M.G.H.; Barthélémy, C.; Janssen, M.J.R.; Joiris, E.; Peters, W.H.M.; Laheij, R.J.F.; Smits, P.; Odou, P.; Jansen, J.B.M.J. Effect of genetic polymorphisms in UDP-glucuronosyltransferase 1A6 (UGT1A6) on acetylsalicylic acid metabolism in healthy female volunteers. Pharmacology, 2009, 83, 237-242.
28. Castillo-Rojas, G.; Ballesteros, M.A.; Ponce de Leon, S.; Morales-Espinosa, R.; Cravioto, A.; Lopez-Vidal, Y. Bleeding peptic ulcers and presence of Helicobacter pylori by various tests: a case-control study. Eur. J. Gastroenterol. Hepatol., 2002, 14, 1113-1118. (Pubitemid 35178772)
29. Hochain, P.; Berkelmans, I.; Czernichow, P.; Duhamel, C.; Tranvouez, J.L.; Lerebours, E.; Colin, R. Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study. Eur. J. Gastroenterol. Hepatol., 1995, 7, 419-426.